Selling Digital Health to Hospitals and Health Systems: What Actually Works

I've spent 30 years selling and building commercial organizations in digital health — closing contracts with 18 of the top 20 national health plans, scaling companies from pre-revenue to $100M ARR, and navigating commercial strategy across payers, providers, and life sciences. And I can tell you without hesitation: selling to health systems is harder than selling to health plans. The deals are slower, the politics are more complex, and the buyers are more skeptical. But the opportunity is enormous — and for the right solutions, provider organizations are among the most motivated buyers in healthcare.

This is the playbook I've developed working with digital health companies targeting hospitals, IDNs, and health systems. It's not theory. It's what actually closes deals.

Why Provider Sales Is Fundamentally Different

Health plan sales and provider sales share some superficial similarities — both are large, complex enterprise sales with long cycles and multiple stakeholders. But the underlying logic is completely different, and if you don't understand that difference, you'll waste years of effort.

Health plans are financial entities first. They evaluate solutions through the lens of cost, risk, and quality measurement — MLR, Star Ratings, HEDIS. The ROI calculus is relatively clean: does this reduce cost or improve a measurable quality outcome we're paid on?

Health systems are clinical and operational entities first. They're managing throughput, workforce, patient satisfaction, regulatory compliance, and increasingly, population health. They're also navigating a brutal financial environment — thin margins, labor cost pressure, and reimbursement uncertainty. The ROI calculus is messier, the clinical credibility bar is higher, and the internal politics are significantly more complex.

Health systems don't buy technology. They buy outcomes they can measure, stories they can tell their board, and solutions that don't create new problems for their clinical staff.

Know Your Buyer: The Provider Org Stakeholder Map

One of the most common mistakes I see is companies targeting the wrong person first. In health system sales, who you engage first — and in what order — matters enormously. The stakeholder map is different depending on your solution category, but these are the people who show up in almost every provider enterprise deal:

The Three Budget Buckets — And How to Get Into the Right One

One of the most tactical things I can tell you about health system sales is this: which budget your solution comes out of determines your sales cycle length, your champion, and your contracting process. There are three buckets, and they are not equal.

The single fastest way to accelerate a health system deal is to help your champion identify which budget your solution fits and give them the language to position it internally. Most champions want to buy — they just don't know where to find the money. If you can answer that question for them, you become a partner instead of a vendor.

Clinical Evidence Is Not Optional — It's the Cost of Entry

Health plan buyers will sometimes move on a pilot with limited evidence if the economics are compelling. Health system CMOs will not. Clinical credibility is the first filter in every provider sales process, and companies that haven't invested in it are wasting time trying to close provider deals.

What "clinical evidence" actually means varies by the sophistication of the health system and the category of your solution:

• Peer-reviewed publication: The gold standard. If you have a published study in a recognized journal showing clinical impact, it changes the conversation with CMOs immediately. Not every company can afford this early, but it's worth investing in.
• IRB-approved study or registered clinical trial: Demonstrates scientific rigor even before results are published. Many health systems will engage as a clinical partner if you have an IRB-approved study, which both validates your solution and builds the relationship.
• Retrospective outcomes data: If you have real-world outcomes data from existing deployments — even from health plans — work with a biostatistician to analyze and present it properly. Health system CMOs know the difference between a marketing claim and an analyzed dataset.
• Reference site: A health system peer who will vouch for your solution's clinical impact carries enormous weight. Nothing closes a provider deal faster than a CMO call with a peer who says "this works."

IDNs vs. Independent Hospitals: Very Different Animals

Integrated Delivery Networks (IDNs) and independent community hospitals are not the same buyer, and treating them as such is a mistake.

Large IDNs — think Ascension, CommonSpirit, Intermountain, HCA, Northwell — have centralized procurement, national contracting vehicles, and dedicated innovation or digital health teams. The advantage: if you can get a system-level contract, you can scale across hundreds of facilities. The disadvantage: the sales cycle is very long, the committee structure is thick, and displacing an incumbent is extremely difficult. For early-stage companies, trying to land a national IDN contract as your first provider deal is usually a mistake. The cycle is too long, the requirements too onerous, and the timeline too unpredictable.

Independent community hospitals and regional health systems are a different story. They're faster to decide, more willing to work with emerging companies, and more likely to give you a genuine pilot environment. The tradeoff is scale — but as a reference site, a strong regional health system is just as credible as a large IDN.

Your first provider deal should be with the system most likely to say yes and give you a real outcome — not the most prestigious logo you can pursue.

The Value-Based Care Wedge — Your Fastest Path Into Provider Organizations

The single most important commercial trend in provider sales right now is the acceleration of value-based care contracts. As health systems take on more risk — through ACOs, Medicare Shared Savings Program participation, direct contracting, and commercial risk arrangements — they're developing a payer-like mindset about managing cost and quality. This is your opening.

Health systems in risk-bearing arrangements are actively looking for solutions that help them:

• Reduce avoidable ED visits and readmissions among attributed populations
• Improve chronic disease management and medication adherence
• Close HEDIS care gaps that affect their shared savings calculations
• Identify and engage high-risk patients before they deteriorate
• Demonstrate quality improvement to their payer partners

If your solution addresses any of these, you have a value-based care story — and value-based care is where provider organizations have both the urgency and the budget authority to move quickly. The VP of Population Health becomes your champion, the ROI is tied to shared savings that are already flowing, and the contracting can often happen outside the traditional capital budget cycle.

What the Companies That Close Provider Deals Do Differently

• They invest in clinical relationships before commercial ones. The best provider deals start with a clinical champion who becomes an internal advocate — not with a sales call to a procurement office.
• They have a clear workflow integration story. The number one objection in provider sales is "how does this work with Epic?" Have a crisp, credible answer before your first meeting.
• They price for OpEx. SaaS-style subscription pricing that hits a department's operating budget closes faster than capital purchase models in almost every provider environment.
• They build reference sites deliberately. Before pursuing large IDNs, they close a smaller system that they can use as a reference — and they structure that engagement to generate publishable outcomes data.
• They engage procurement early. Waiting until the clinical and financial decision is made to loop in procurement is a mistake. Procurement can add 90–120 days to any deal. Start that process in parallel, not in sequence.
• They understand the governance structure. Health systems have medical executive committees, technology steering committees, and vendor approval processes. Knowing which committees need to approve your deal — and building a timeline around them — separates experienced provider sellers from everyone else.